FDA Removes Black-Box Warnings from Menopause Patches
The US Food and Drug Administration said it removed black-box warnings about cardiovascular disease, breast cancer and dementia from three estrogen patches used to treat menopause. The agency did not convene its advisory committee or provide detailed scientific explanation; this follows a similar February action and comes amid nationwide patch shortages.
Developing story